Infective Endocarditis in Patients with Mitral Annular Calcification: Clinical and Echocardiographic Presentation,

Gaspard Suc1, Lawrence Lau1, Serah Seo1

  • 1Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

CJC Open
|March 2, 2026
PubMed
Abstract

Insights

Mitral annular calcification (MAC) complicates infective endocarditis (IE), often affecting the mitral valve with large vegetations. Management challenges persist, with surgery often indicated but underutilized in this high-risk patient group.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Echocardiography

Background:

  • Mitral annular calcification (MAC) presents unique challenges in managing infective endocarditis (IE).
  • Understanding the specific echocardiographic features, management strategies, and outcomes of IE in patients with MAC is crucial.

Purpose of the Study:

  • To characterize the echocardiographic features of infective endocarditis (IE) in patients with mitral annular calcification (MAC).
  • To assess the management and clinical outcomes of IE in this specific patient population.

Main Methods:

  • Retrospective review of cases discussed in IE multidisciplinary meetings from 2021-2024.
  • Collection of clinical data, imaging findings, and outcomes through chart review for patients with possible or definite IE and moderate-to-severe MAC.

Main Results:

  • Of 741 patients, 51 (7%) had IE with moderate-severe MAC. The mitral valve was involved in 24 patients (47%), more frequently in women.
  • Patients with mitral IE presented with large vegetations (median 13 mm), significant mitral regurgitation (54%), and a characteristic "rocking" motion of MAC in some cases.
  • Surgical indications were high (63%), but only 40% underwent surgery due to perceived risk. In-hospital mortality was similar between mitral and non-mitral IE groups (29% vs. 15%).

Conclusions:

  • Infective endocarditis with mitral annular calcification frequently involves the mitral valve, characterized by large, mobile vegetations and a "rocking" MAC appearance.
  • Despite high surgical indications, underutilization of surgery due to perceived risk highlights a critical management gap in this high-risk IE population.

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
292
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
386
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
856
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
973
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
450
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
367